NCT02536105View on ClinicalTrials.gov

PK/PD Pediatric ADHD Classroom Study

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate HCl ER tablets 1

DRUG

Placebo

DRUG

Methylphenidate HCl ER tablets 2

DRUG

Methylphenidate HCl ER for suspension

Trial Locations (2)

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

collaborator

Center for Psychiatry And Behavioral Medicine Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT02536105 - PK/PD Pediatric ADHD Classroom Study | Biotech Hunter | Biotech Hunter